Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trial.

Goldhaber, S Z

Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trial. [electronic resource] - Journal of the American College of Cardiology Jul 1992 - 24-30 p. digital

Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

0735-1097

10.1016/0735-1097(92)90132-7 doi


Acute Disease
Adult
Aged
Cause of Death
Confidence Intervals
Drug Administration Schedule
Female
Humans
Male
Middle Aged
Pulmonary Embolism--blood
Radiography
Recombinant Proteins--therapeutic use
Thrombolytic Therapy--adverse effects
Tissue Plasminogen Activator--therapeutic use
Urokinase-Type Plasminogen Activator--therapeutic use